. Author manuscript; available in PMC: 2017 Jun 20.

Published in final edited form as: Biol Blood Marrow Transplant. 2008 Dec;14(12):1394–1400. doi: 10.1016/j.bbmt.2008.09.021

Table 3.

Cox Regression Analysis—Relapse

Factor	Relative Risk (95% C.I.)	P
Group
RD^*	1.0
UCB	0.3 (0.0–2.4)	.28
Unrelated (HLA mm)	0.0 (0.0–.)	NE
Unrelated (HLA match)	2.3 (0.6–9.5)	.25
R/D CMV serostatus
Negative/negative^*	1.0
Positive/negative	0.7 (0.2–2.6)	.62
Negative/positive	2.7 (0.8–9.9)	.13
Positive/positive	8.4 (2.4–28.8)	<.01
Number of induction regimens prior to CR
1^*	1.0
2+	6.6 (1.9–23.1)	<.01
Grade II–IV acute GVHD
no^*	1.0
yes (time-dependent)	0.6 (0.3–1.4)	.24

CMV indicates cytomegalovirus; CR, complete remission; GVHD, graft-versus-host disease; R/D, matched related donor; UCB, umbilical cord blood.

Reference group.